Guidance

National protocol for Spikevax (formerly COVID-19 Vaccine Moderna)

This protocol is for the administration of Spikevax to individuals in accordance with the national COVID-19 vaccination programme.

• From: UK Health Security Agency
• Published: 8 April 2021
• Last updated: 1 April 2022
  Show all updates

  1. 1 April 2022

     Removed expired protocol (v05.00).

  2. 28 March 2022

     Added version 06.00 – see page 4 for change history.

  3. 20 January 2022

     Added version 05.00 – details of changes on page 4.

  4. 17 December 2021

     Added version 04.00a – details of changes on page 4.

  5. 16 December 2021

     Added version 04.00 – details of changes on page 4.

  6. 9 December 2021

     Added version 03.00 – details of changes on page 3.

  7. 8 October 2021

     Added latest version (see page 2 for change history).

  8. 8 April 2021

     First published.

This publication was withdrawn on 6 April 2023

This protocol has been superseded by the COVID-19 adult and children 5 to 17 years national protocols.

Applies to England

Documents

[Withdrawn] National protocol for Spikevax (v06.00)

Ref: UKHSA gateway number GOV-11808

MS Word Document, 212 KB

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This protocol is for the administration of Spikevax (formerly COVID-19 Vaccine Moderna) by appropriately-trained persons.

National protocol for Spikevax (formerly COVID-19 Vaccine Moderna) v06.00 is valid from 31 March 2022 to 1 April 2023.